Stay updated on 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.

Latest updates to the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a site version update or maintenance patch rather than a change to the study details.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s UI release marker was updated from revision v3.5.2 to v3.5.3, indicating a platform/version change without changing the underlying study information.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check67 days agoChange Detected- Revision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check81 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check102 days agoChange DetectedMinor system update shows Revision: v3.4.2 replacing v3.4.1; no impact on study details, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.